Oragenics, Inc. (OGEN) Total liabilities 2012–2024
Oragenics, Inc. (OGEN) total liabilities at each fiscal year-end, per SEC filings.
$1.8MFY2024 · since FY2012: $9.4M → $1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $1.8M | +2.8% |
| FY2023 | $1.7M | +0.2% |
| FY2022 | $1.7M | — |
| FY2018 | $898,522 | -33.1% |
| FY2017 | $1.3M | +28.3% |
| FY2016 | $1.0M | +31.5% |
| FY2015 | $796,272 | -19.8% |
| FY2014 | $992,847 | -21.0% |
| FY2013 | $1.3M | -86.7% |
| FY2012 | $9.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice